Publications (151,671)

Search

Speech differences between CI users with pre- and postlingual onset of deafness detected by speech processing methods on voiceless to voice transitions

Arias Vergara T, Orozco Arroyave JR, Vasquez Correa J, Nöth E, Schuster M, Gollwitzer S, Högerle C (2019)

Conference contribution, Abstract of a poster

DIFFERENT NUTRIENT INTAKE AND PREVALENCE OF GASTROINTESTINAL COMORBIDITIES IN WOMEN WITH ENDOMETRIOSIS

Schink M, Konturek PC, Herbert SL, Renner SP, Burghaus S, Blum S, Fasching P, et al. (2019)

Journal article

A new approach for the stabilization of amorphous drug nanoparticles during continuous antisolvent precipitation

Trzenschiok H, Distaso M, Peukert W (2019)

Journal article

ISWC 2018: Towards Smarter Wearable Technologies That Blend With Our Bodies

Amft O, Van Laerhoven K (2019)

Journal article, Editorial

Maschinelle Lernverfahren für die Praxis - Praxisnahes Qualifizierungskonzept für Industriesegmente wie Automotive und Maschinenbau

Mühlbauer M, Würschinger H, Hanenkamp N (2019)

Journal article

Portable and Scalable High Voltage Circuits for Automotive Applications in BiCMOS Processes

Easwaran SN, Camdzic S, Weigel R (2019)

Conference contribution

Corrigendum to manuscript ”Dynamics of dissolved organic carbon in hillslope discharge: Modeling and challenges” (Journal of Hydrology (2017) 546 (309–325), (S0022169416308526), (10.1016/j.jhydrol.2016.12.054))

Dusek J, Vogel T, Dohnal M, Barth J, Sanda M, Marx A, Jankovec J (2019)

Journal article, Erratum

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy

Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. (2019)

Conference contribution

EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN THE GIACTA TRIAL

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. (2019)

Conference contribution

Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial

Tahir H, Mease PJ, Kavanaugh A, Reimold A, Rech J, Hall S, Geusens P, et al. (2019)

Conference contribution

‹ 1 ... 5,518 5,519 5,520 5,521 5,522 ... 15,168 ›